Molecular Nucleic Acid TestingX
Molecular diagnostics include clinical tests with nucleic acid analytes or targets and represent some of the fastest growing and most dynamic clinical diagnostics markets. Exceeding $6 billion in global market volume, clinical molecular diagnostics are the leading application of nucleic acid tests. Kalorama Information offers specialized research in related markets of molecular point-of-care (POC) diagnostics, next-generation sequencing (NGS), molecular infectious disease diagnostics, and cancer diagnostics. Included in this section is information on the latest in molecular screening that catches infectious diseases such as HIV and Influenza, offering developments in the market soon to be used in molecular diagnostic treatments. Find the most up to date information on devices already on the market or still in development that will quickly determine appropriate treatment methods for patients, and understand the paradigm shift from curative medicine to predictive, personalized, and preemptive patient treatment.
The field of pharmacogenetics promises to open up new opportunities for the diagnostic industry at the same time it opens the door to more effective therapeutics. Pharmacogenetics is based on the principle that the effects of a given medication when administered to a patient are determined, at least in part, by his or her genetic […]
October 1, 2004
Molecular diagnostics are seen as being a major breakthrough in medical science. While the technology itself has broad applications to such areas as agricultural bioterrorism and environmental science, medical and medical research applications have provided the primary focus. As a result, great things have been predicted for the development and use of new therapeutics based […]
May 1, 2004